Stocks
Celularity Inc.CELU
NASDAQHealthcareBiotechnology$0.98
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing allogeneic cell therapies derived from the human placenta, with a focus on oncology and wound-healing applications. Its pipeline includes off-the-shelf natural killer cell and mesenchymal stem cell candidates, and investors track it for potential advances in regenerative medicine and cancer immunotherapy.
52W Range: $0.56-$2.55
Congressional Interest in Celularity Inc. (CELU)
No congressional trades have been disclosed for Celularity Inc. (CELU) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CELU?
No congressional trades found for this stock.